VTRS

VTRS

USD

Viatris Inc. Common Stock

$10.490+0.050 (0.479%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$10.440

Kõrge

$10.600

Madal

$10.360

Maht

17.83M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

12.1B

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

9.46M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $6.85Praegune $10.490Kõrge $13.55

Seotud uudised

Analyst Upgrades

Truist Securities Initiates Coverage On Viatris with Buy Rating, Announces Price Target of $15

Truist Securities analyst Srikripa Devarakonda initiates coverage on Viatris with a Buy rating and announces Price Target of $15.

Vaata rohkem
Truist Securities Initiates Coverage On Viatris with Buy Rating, Announces Price Target of $15
PR Newswire

Viatris to Participate in Upcoming Investor Conferences

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in ...

Vaata rohkem
Viatris to Participate in Upcoming Investor Conferences
PR Newswire

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2025. This ...

Vaata rohkem
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row